Literature DB >> 10918192

Allelic losses demonstrate monoclonality of multifocal bladder tumors.

J Louhelainen1, H Wijkström, K Hemminki.   

Abstract

The clonality of multifocal bladder tumors has been studied over the years with some controversial results. We have examined 5 patients with 2-11 low-grade superficial multifocal bladder tumors for loss of heterozygosity (LOH) at 87 loci on 9 chromosomes. When LOH was detected at a given marker, the tumors consistently showed deletion of a specific allele, suggesting the monoclonality of the patients' tumors. No allelic imbalancies were detected between heterozygote alleles, and the allelic losses were only slightly biased toward the loss of the shorter alleles as the overall ratio was 0.48 +/- 0.10 (0.50 for nonbiased). We calculated the probabilities for monoclonality using binomial distribution. The use of multiple tumors with multiple microsatellite markers gives high statistical power for the calculation. The combined probabilities for monoclonality varied from 0.984 to (1-4 x 10(-28)). Thus, in most (4/5) cases, the probability for polyclonality was <2 x 10(-16). These results demonstrate that superficial multifocal bladder tumors are most likely of monoclonal origin. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10918192

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  Tumor evolution and progression in multifocal and paired non-invasive/invasive urothelial carcinoma.

Authors:  Joshua I Warrick; Daniel H Hovelson; Anmol Amin; Chia-Jen Liu; Andi K Cani; Andrew S McDaniel; Venkata Yadati; Michael J Quist; Alon Z Weizer; J Chad Brenner; Felix Y Feng; Rohit Mehra; Catherine S Grasso; Scott A Tomlins
Journal:  Virchows Arch       Date:  2014-12-11       Impact factor: 4.064

2.  Comparative genomic hybridisation as a supportive tool in diagnostic pathology.

Authors:  M M Weiss; E J Kuipers; S G M Meuwissen; P J van Diest; G A Meijer
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

3.  FGFR3, HRAS, KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy.

Authors:  Lucie C Kompier; Irene Lurkin; Madelon N M van der Aa; Bas W G van Rhijn; Theo H van der Kwast; Ellen C Zwarthoff
Journal:  PLoS One       Date:  2010-11-03       Impact factor: 3.240

Review 4.  PhyloOncology: Understanding cancer through phylogenetic analysis.

Authors:  Jason A Somarelli; Kathryn E Ware; Rumen Kostadinov; Jeffrey M Robinson; Hakima Amri; Mones Abu-Asab; Nicolaas Fourie; Rui Diogo; David Swofford; Jeffrey P Townsend
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2016-10-31       Impact factor: 11.414

5.  Clonality analysis of synchronous lesions of cervical carcinoma based on X chromosome inactivation polymorphism, human papillomavirus type 16 genome mutations, and loss of heterozygosity.

Authors:  Xinrong Hu; Tianyun Pang; Anna Asplund; Jan Pontén; Monica Nistér
Journal:  J Exp Med       Date:  2002-04-01       Impact factor: 14.307

6.  On the emergence of multifocal cancers.

Authors:  Dominik Wodarz; Yoh Iwasa; Natalia L Komarova
Journal:  J Carcinog       Date:  2004-10-01

7.  Genetic analysis of multifocal superficial urothelial cancers by array-based comparative genomic hybridisation.

Authors:  H Kawanishi; T Takahashi; M Ito; Y Matsui; J Watanabe; N Ito; T Kamoto; T Kadowaki; G Tsujimoto; I Imoto; J Inazawa; H Nishiyama; O Ogawa
Journal:  Br J Cancer       Date:  2007-06-19       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.